Vivo Bio Tech Ltd

Market Cap ₹( Cr.)
Proj. P/E (x)
Proj. P/BV (x)
Proj. ROE (%)
Proj EV / EBITDA (x)
Proj. Revenue ( Cr.)

Stock View

Last Updated On.

The average score for Vivo Bio Tech Ltd stands at 3 against 2, three months back.

Vivo Bio Tech Limited is an India-based full service pre-clinical clinical research organization (CRO). The Company offers drug development and discovery services to pharmaceutical and biotech companies across the world. The Company offers services in the areas of In vivo and In vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxicokinetic studies, genotoxicity screening, analytical services, and other. It provides both regulatory and non-regulatory IND enabling preclinical development services. It is engaged in screening and evaluating molecules for various pharmacological and therapeutic properties. Specifically for oncology, the Company provides designing and development of syngeneic/xenograft models for evaluation of anti-cancer agents. The Company also customizes In vivo drug metabolism and pharmacokinetics (DMPK) studies to help profile drug candidate in both rodent and non-rodent animal models.

Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required